Scrip

Coronavirus Update: As Pfizer/BioNTech Begin Omicron Vaccine Tests, Regulators Want To Explore Multivalent Route

Plus: One Step Forward For Veklury, Two Steps Back For REGEN-COV

26 Jan 2022

• By Scrip Team

Pfizer explores options for new vaccine update, Veklury expands to non-hospitalized patients but Regeneron and Lilly therapies stopped in face of Omicron efficacy drop-off.

Wuhan 2022 — Wuhan, China: two years on from the initial outbreak, China is preparing for New Year's celebrations and the Winter Olympics, but is still dealing with SARS-CoV2. • Source: Getty Images

Pfizer and BioNTech have launched the first clinical trial of an Omicron version of their COVID-19 vaccine Comirnaty that will study its use both as a booster and in previously unvaccinated people.

Omicron is now the predominant SARS-CoV-2 variant in many parts of the world, and despite its generally less severe symptoms,...